Gerald S. Rork - Lawrence KS James D. Pipkin - Lawrence KS
Assignee:
Merck & Co., Inc. - Rahway NJ
International Classification:
A61K 924 A61K 932 A61K 936
US Classification:
424472
Abstract:
A device is disclosed for the controlled delivery of a beneficial agent, the device consisting of (i) a core comprising at least two layers, wherein at least one layer comprises a beneficial agent and a polymer which forms microscopic gel beads upon hydration and at least one layer which comprises a polymer which forms microscopic gel beads upon hydration; and (ii) an impermeable, insoluble coating which adheres to and surrounds the core and contains apertures which provide an area for the hydration and release of the microscopic gel beads.
John L. Haslam - Lawrence KS Gerald S. Rork - Lawrence KS
Assignee:
Merck & Co., Inc. - Rahway NJ
International Classification:
A61K 3155
US Classification:
424424
Abstract:
The instant invention is directed to an osmotic pump, for the controlled release of diltiazem L-malate to an environment of use, said pump comprising: (A) a core which comprises a therapeutically effective amount of diltiazem L-malate and an effective buffering amount of sodium bitartrate surrounded by (B) a rate controlling water insoluble wall, having a fluid permeability of 6. 96. times. 10. sup. -18 to 6. 96. times. 10. sup. -14 cm. sup. 3 sec/g and a reflection coefficient of less than 0. 5, prepared from: (i) a polymer permeable to water but impermeable to solute and (ii) 0. 1 to 60% by weight, based on the total weight of (i) and (ii), of at least one pH insensitive pore forming additive dispersed throughout said wall.
Gerald S. Rork - Lawrence KS James D. Pipkin - Lawrence KS
Assignee:
Merck & Co., Inc. - Rahway NJ
International Classification:
A61K 924
US Classification:
424473
Abstract:
Controlled delivery of a beneficial agent in a dispersion is provided using (i) a compressed core which contains the beneficial agent, a polymer which forms gelatinous microscopic particles upon hydration, and if desired, an agent to modulate the hydration; and (ii) a water insoluble coating which adheres to and surrounds the core and contains apertures which provide an area for the hydration and release of the dispersion. The release rate of the beneficial agent is a function of the number and size of the apertures in the coating.
Gaylen M. Zentner - Lawrence KS Gerald S. Rork - Lawrence KS Kenneth J. Himmelstein - Irvine CA
Assignee:
Merck & Co., Inc. - Rahway NJ
International Classification:
A61K 964
US Classification:
424465
Abstract:
The instant invention is directed to an osmotic pump comprising: (A) at least one active agent surrounded by (B) a rate controlling water insoluble wall, having a fluid permeability of 6. 96. times. 10. sup. -18 to 6. 96. times. 10. sup. -14 cm. sup. 3 sec/g and a reflection coefficient of less than 1, prepared from: (i) a polymer permeable to water but impermeable to solute and (ii) 0. 1 to 60% by weight, based on the total weight of (i) and (ii), of at least one pH insensitive pore forming additive dispersed throughout said wall.
Controlled Release Drug Dispersion Delivery Device
Gerald S. Rork - Lawrence KS James D. Pipkin - Lawrence KS
Assignee:
Merck & Co., Inc. - Rahway NJ
International Classification:
A61K 924
US Classification:
424473
Abstract:
A device for the controlled delivery of a beneficial agent as a gelatinous dispersion consisting of (i) a core which contains a beneficial agent, a polymer which forms gelatinous microscopic particles upon hydration and if desired an agent to modulate the hydration of the polymer; and (ii) an impermeable, insoluble coating which adheres to and surrounds the core and contains apertures which provide an area for the hydration and release of a dispersion comprising gelatinous microscopic particles.
Gerald S. Rork - Lawrence KS James D. Pipkin - Lawrence KS
Assignee:
Merck & Co., Inc. - Rahway NJ
International Classification:
A61K 924
US Classification:
424473
Abstract:
A device for the controlled delivery of a beneficial agent as a gelatinous dispersion consisting of (i) a core which contains a beneficial agent, a polymer which forms gelatinous micoroscopic particles upon hydration and if desired an agent to modulate the hydration of the polymer; and (ii) an impermeable, insoluble coating which adheres to and surrounds the core and contains apertures which provide an area for the hydration and release of a disperson comprising gelatinous microscopic particles.
Gaylen M. Zentner - Lawrence KS Kenneth J. Himmelstein - Irvine CA Gerald S. Rork - Lawrence KS
Assignee:
Merck & Co., Inc. - Rahway NJ
International Classification:
A61K 964
US Classification:
424456
Abstract:
The instant invention is directed to a multiparticulate osmotic pump, for the controlled release of a pharmaceutically active agent to an environment of use, said pump comprising: (I) a carrier medium which does not maintain its integrity in the environment of use; (II) a multiple of tiny osmotic pump elements each consisting essentially of: (A) a core comprises at least one pharmacologically active agent soluble in an external fluid, or a mixture of an agent having a limited solubility in the external fluid with an osmotically effective solute that is soluble in the fluid, which exhibit an osmotic pressure gradient across the wall against the external fluid surrounded by (B) a rate controlling water insoluble wall, having a fluid permeability of 6. 96. times. 10. sup. -18 to 6. 96. times. 10. sup. 14 cm. sup. 3 sec/g and a reflection coefficient of less than 0. 5, prepared from: (i) a polymer permeable to water but impermeable to solute and (ii) 0.
John L. Haslam - Lawrence KS Gerald S. Rork - Lawrence KS
Assignee:
Merck & Co., Inc. - Rahway NJ
International Classification:
A61K 3155
US Classification:
424424
Abstract:
The instant invention is directed to a multiparticulate osmotic pump, for the controlled release of diltiazem L-malate to an environment of use, said pump comprising: (I) a carrier medium which does not maintain its integrity in the environment of use; (II) a multiple of tiny osmotic pump elements each comprising: (A) a core comprises diltiazem L-malate and an effective buffering amount of sodium bitartrate surrounded by (B) a rate controlling water insoluble wall, having a fluid permeability of 6. 96. times. 10. sup. -18 to 6. 96. times. 10. sup. -14 cm. sup. 3 sec/g and a reflection coefficient of less than 0. 5, prepared from: (i) a polymer permeable to water but impermeable to solute and (ii) 0. 1 to 60% by weight, based on the total weight of (i) and (ii), of at least one pH insensitive pore forming additive dispersed throughout said wall, wherein the total amount of diltiazem L-malate in all of the osmotic pump elements is a therapeutically effective amount.
Youtube
Gerald Scarfe - 'Drawing Blood' documentary ...
A documentary about the artist, the highlight for me being his Royal F...
Duration:
50m 48s
Gerhard Richter: 40 Years of Painting | Docum...
Described in Art Review as the world's most influential and expensive ...
Duration:
13m 55s
BURNING DOWN THE ECONOMY - #TRADING #INVESTIN...
The Money Flow Trading System hard copy & eBook Getting Started with...
Duration:
54m 41s
OIL TRADE BLOWING UP? - 12-5-22 - #TRADING #I...
The Money Flow Trading System hard copy & eBook Grab free eBook, "Yo...